The use of immunological markers in IDDM after more than 20 years from ICA description

Diabetes Metab Rev. 1996 Jul;12(2):121-6. doi: 10.1002/(SICI)1099-0895(199607)12:2<121::AID-DMR160>3.0.CO;2-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Autoantibodies / immunology*
  • Biomarkers*
  • Diabetes Mellitus, Type 1 / immunology*
  • Gangliosides / immunology
  • Glutamate Decarboxylase / immunology
  • Humans
  • Insulin Antibodies / immunology
  • Islets of Langerhans / immunology
  • Mice
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases / immunology

Substances

  • Autoantibodies
  • Biomarkers
  • GM2-1 ganglioside
  • Gangliosides
  • Insulin Antibodies
  • islet cell antibody
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases
  • Glutamate Decarboxylase